Suppr超能文献

阿尔茨海默病研究的多媒体辅助同意书

Multimedia Aided Consent for Alzheimer's Disease Research.

作者信息

Palmer Barton W, Harmell Alexandrea L, Dunn Laura B, Kim Scott Y, Pinto Luz L, Golshan Shahrokh, Jeste Dilip V

机构信息

a Veterans Affairs San Diego Healthcare System , San Diego , California , USA.

b Veterans Medical Research Foundation , San Diego , California , USA.

出版信息

Clin Gerontol. 2018 Jan-Feb;41(1):20-32. doi: 10.1080/07317115.2017.1373177. Epub 2017 Nov 28.

Abstract

OBJECTIVES

Optimizing the research consent process simultaneously fosters respect for autonomy and protection of those with diminished capacity for autonomy. This study evaluated the effectiveness of an enhanced research consent procedure, employing multimedia disclosure and corrective feedback, in improving decisional capacity among 114 people with mild-to-moderate Alzheimer's disease (AD) and 134 non-psychiatric comparison (NC) subjects.

METHODS

Participants were randomized to consent type (routine versus enhanced) and protocol type (lower versus higher risk). Outcomes included a 5-item questionnaire assessing immediate comprehension, MacArthur Competence Assessment Tool for Clinical Research assessing four components of decision-making capacity, and categorical decisional capacity (based on a cut-score established in reference to expert judgments for a subset of participants).

RESULTS

There was no significant effect of the enhanced consent procedure, relative to routine consent, on immediate comprehension or decisional capacity.

CONCLUSIONS

Multimedia tools do not appear to be the solution to better consent for AD research.

CLINICAL IMPLICATIONS

Given the ethical primacy of informed consent and issues of justice for impaired populations who might be harmed by an absence of research-based treatment advances, continued search for ways to more meaningfully engage people with AD in the consent or assent process is warranted.

摘要

目的

优化研究同意程序既能促进对自主性的尊重,又能保护自主性能力减弱的人群。本研究评估了一种强化研究同意程序(采用多媒体披露和纠正反馈)在提高114名轻度至中度阿尔茨海默病(AD)患者和134名非精神科对照(NC)受试者决策能力方面的有效性。

方法

参与者被随机分为同意类型(常规与强化)和方案类型(低风险与高风险)。结果包括一份评估即时理解能力的5项问卷、评估决策能力四个组成部分的麦克阿瑟临床研究能力评估工具,以及分类决策能力(基于参考一部分参与者的专家判断确定的得分标准)。

结果

相对于常规同意,强化同意程序对即时理解能力或决策能力没有显著影响。

结论

多媒体工具似乎并非改善AD研究同意情况的解决方案。

临床意义

鉴于知情同意的伦理首要性以及对于可能因缺乏基于研究的治疗进展而受到伤害的受损人群的公平问题,有必要继续寻找让AD患者更有意义地参与同意或赞同过程的方法。

相似文献

1
Multimedia Aided Consent for Alzheimer's Disease Research.
Clin Gerontol. 2018 Jan-Feb;41(1):20-32. doi: 10.1080/07317115.2017.1373177. Epub 2017 Nov 28.
2
Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial.
Schizophr Bull. 2009 Jul;35(4):719-29. doi: 10.1093/schbul/sbm148. Epub 2008 Jan 31.
3
Determinants of Capacity to Consent to Research on Alzheimer's disease.
Clin Gerontol. 2017;40(1):24-34. doi: 10.1080/07317115.2016.1197352. Epub 2016 Jun 7.
4
The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.
JBI Database System Rev Implement Rep. 2015 Oct;13(10):82-94. doi: 10.11124/jbisrir-2015-2304.
10
Research with Alzheimer's disease subjects: informed consent and proxy decision making.
J Am Geriatr Soc. 1992 Sep;40(9):950-7. doi: 10.1111/j.1532-5415.1992.tb01995.x.

引用本文的文献

1
Predictors of Decisional Capacity in Alzheimer's Disease Biomarker Test Candidates.
Nurs Res. 2025;74(2):108-114. doi: 10.1097/NNR.0000000000000793. Epub 2024 Nov 15.
2
Consent for Research Involving Spanish- and English-Speaking Latinx Adults With Schizophrenia.
Schizophr Bull. 2024 Apr 30;50(3):673-683. doi: 10.1093/schbul/sbad159.
3
Decision-Making Support for People With Alzheimer's Disease: A Narrative Review.
Front Psychol. 2021 Nov 12;12:750803. doi: 10.3389/fpsyg.2021.750803. eCollection 2021.
4
Informed Consent or Assent Strategies for Research With Individuals With Deafblindness or Dual Sensory Impairment: A Scoping Review.
Arch Rehabil Res Clin Transl. 2021 Feb 22;3(2):100115. doi: 10.1016/j.arrct.2021.100115. eCollection 2021 Jun.
5
Determining medical decision-making capacity in brain tumor patients: why and how?
Neurooncol Pract. 2020 Jul 16;7(6):599-612. doi: 10.1093/nop/npaa040. eCollection 2020 Dec.
7
Informed consent, therapeutic misconception, and clinical trials for Alzheimer's disease.
Int J Geriatr Psychiatry. 2020 May;35(5):430-435. doi: 10.1002/gps.5262. Epub 2020 Jan 26.

本文引用的文献

1
Determinants of Capacity to Consent to Research on Alzheimer's disease.
Clin Gerontol. 2017;40(1):24-34. doi: 10.1080/07317115.2016.1197352. Epub 2016 Jun 7.
3
Assessment of Healthcare Decision-making Capacity.
Arch Clin Neuropsychol. 2016 Sep;31(6):530-40. doi: 10.1093/arclin/acw051. Epub 2016 Aug 22.
5
There Are All Kinds of Rights.
Hastings Cent Rep. 2016 Mar-Apr;46(2):insidebackcover. doi: 10.1002/hast.549.
6
Protecting the Rights of Persons With Disabilities: An International Convention and Its Problems.
Psychiatr Serv. 2016 Apr 1;67(4):366-8. doi: 10.1176/appi.ps.201600050.
7
Supported decision making: the rights of people with dementia.
Nurs Stand. 2016 Mar 23;30(30):38-44. doi: 10.7748/ns.30.30.38.s45.
8
Alzheimer's disease: Targeting the Cholinergic System.
Curr Neuropharmacol. 2016;14(1):101-15. doi: 10.2174/1570159x13666150716165726.
9
Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success.
Clin Ther. 2015 Aug;37(8):1632-42. doi: 10.1016/j.clinthera.2015.07.006. Epub 2015 Aug 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验